● Investor

Taiho Ventures

Corporate venture arm of Taiho Pharmaceutical investing in oncology and healthcare innovation

Venture CapitalPrinceton, United StatesSeries C → Series B

Portfolio

3

companies tracked

Rounds · 12mo

3

participated in

Est. deployed · 12moEstimated by summing amounts of tracked rounds. Actual check sizes vary and often aren't disclosed.

$236M

sum of tracked rounds

Top stage

Series B

by round count

Recent activity

Rounds LatestRounds has tracked from this investor.

Series C$52MApr 16
Series B$77MMar 18
EpiBiologicsSan Francisco
Series B$107MJan 8

Where they invest

By stage · rounds, 12mo

Series B2
Series C1

Frequent co-investors

No repeat co-investors yet.